Clinical trial

Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)

NCT02776072

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-05-01

PhaseN/A

Study timeline

Study start (unknown)2016-05-01Date precision: month

Registry last updated2017-03-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BostonMassachusetts, United States2 ColumbusOhio, United States2 RosarioSanta Fe Province, Argentina2 Hradec KrálovéCzechia2 New YorkNew York, United States1 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 ClevelandOhio, United States1 PittsburghPennsylvania, United States1 PortlandOregon, United States1 JacksonvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02776072 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.